FITZGERALD THOMAS A (VP, Chief Financial Officer) purchased 9.4% of their position (12K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $15.2K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/17/2022ACC: 0001104659-22-072369
DirectorOfficer· VP, Chief Financial Officer
Since Jul 2021
+12K
Net shares
Net buyer
$15.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
$1.27
Trade value
$15.24K
% of position
9.4%
6/16/2022
127.38K→139.38K
Total
Net shares
+12K
Net value
$15.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2022 | P · Purchase | +12K | $1.27 | $15.24K | 9.4% | 127.38K | 139.38K |
| Total | +12K | $15.24K | ||||||
Derivative Transactions0
No derivative transactions reported